The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Avalon Ventures Vii L P since 2007.
The trader's CIK number is 1318999.
At the time of the last reporting, Avalon Ventures Vii L P was the 10% Owner of Akesis Pharmaceuticals, Inc.. (stock ticker symbol AKES.OB).
Also see all insider trading activities at Akesis Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | AKES.OB | 2,352,942 | $2,000,000 | 0 | $0 | 0 | $0 |
| 2007 | AKES.OB | 317,500 | $164,962 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-03-25 | AKES.OB | Buy | 2,352,942 | .85 | 2,000,000 |
| 2007-11-19 | AKES.OB | Buy | 20,000 | .72 | 14,500 |
| 2007-09-12 | AKES.OB | Buy | 15,000 | .56 | 8,445 |
| 2007-09-13 | AKES.OB | Buy | 7,500 | .66 | 4,950 |
| 2007-09-11 | AKES.OB | Buy | 12,500 | .52 | 6,437 |
| 2007-09-10 | AKES.OB | Buy | 25,000 | .53 | 13,200 |
| 2007-09-06 | AKES.OB | Buy | 20,000 | .48 | 9,540 |
| 2007-09-04 | AKES.OB | Buy | 15,000 | .47 | 7,050 |
| 2007-09-05 | AKES.OB | Buy | 20,000 | .47 | 9,500 |
| 2007-08-30 | AKES.OB | Buy | 15,000 | .49 | 7,350 |
| 2007-08-31 | AKES.OB | Buy | 17,500 | .50 | 8,750 |
| 2007-08-29 | AKES.OB | Buy | 10,000 | .48 | 4,800 |
| 2007-08-08 | AKES.OB | Buy | 5,000 | .47 | 2,350 |
| 2007-08-24 | AKES.OB | Buy | 5,000 | .51 | 2,550 |
| 2007-08-23 | AKES.OB | Buy | 15,000 | .50 | 7,500 |
| 2007-08-22 | AKES.OB | Buy | 10,000 | .51 | 5,050 |
| 2007-08-20 | AKES.OB | Buy | 10,000 | .51 | 5,050 |
| 2007-08-21 | AKES.OB | Buy | 55,000 | .53 | 29,315 |
| 2007-08-16 | AKES.OB | Buy | 35,000 | .47 | 16,275 |
| 2007-08-17 | AKES.OB | Buy | 5,000 | .47 | 2,350 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Avalon Ventures Vii L P (10% Owner of Akesis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.